search - Mayo Clinic Laboratories

Web:	mayocliniclabs.com
Email:	mcl@mayo.edu
Telephone:	800-533-1710
International:	+1 855-379-3115
Values are valid only on day of printing

Chromogenic Factor VIII and IX Assays: Impact on Diagnosis and Management of Hemophilia - Insights

In this month’s “Hot Topic,” Rajiv Pruthi, M.B.B.S., will discuss different types of hemophilia along with their pathologic basis. He will also cover various types of factor assays such as one stage and chromogenic factor assays for...

Mayo Clinic Laboratory and Pathology Research Roundup: March 2 - Insights

This week’s Research Roundup highlights high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology.

Clean and dry kidney stones - Insights

To optimize laboratory evaluation of kidney stones, specimens must be both clean and dry. The sensitivity of the analytical method used to determine kidney stone composition requires samples be completely dry, since excess water in the...

On Demand - Insights

Online education and training provided through pre-recorded presentations and interactive learning modules.

Phlebotomy Top Gun: Order of Draw-Do We Still Care? - Insights

In this month’s “Hot Topic,” Brad Karon, M.D., Ph.D., will cover the need and evidence behind following the order of draw recommendations for routine blood collection. Specifically, does evidence demonstrate a need to collect serum tubes...

MCL Neurogenetics Delivering Precision Results Through ExpertBacked Advanced Evaluations MC2775732

MCL Neurogenetics Delivering Precision Results ExpertBacked Advanced Evaluations NEUROGENETICS DELIVERING PRECISION RESULTS EXPERT BACKED ADVANCED EVALUATIONS neurogenetic testing unparalleled scope includes molecular

Pharmacogenomics - Insights

Mayo Clinic Laboratories’ pharmacogenomic testing offers superior analytical quality, enabling targeted detection of more clinically actionable alleles than other testing.

Staffing to Workload: Operational Needs - Insights

Mike Baisch, Systems Engineer at Mayo Clinic, discusses the mechanics of performing a staffing-to-workload analysis in the testing laboratories. There are three primary areas of focus with staffing needs: direct effort, indirect effort, and...

June 2023 - Clinical Chemistry - Insights

This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Chemistry.

Cross-laboratory collaboration accelerates gold-standard SRA testing - Insights

Utilizing testing capabilities of two separate laboratory facilities, Mayo Clinic Laboratories’ new serotonin release assay (SRA) is a gold-standard test supported by decades of clinical hematopathologic experience and advanced mass...

Heparin Induced Thrombocytopenia (HIT) and the Role of Serotonin Release Assay (SRA) - Insights

In this month's "Hot Topic," Rajiv Pruthi, M.B.B.S., discusses heparin induced thrombocytopenia (HIT), approach diagnosis, and the role of the functional serotonin release assay (SRA).

August 2023 - Lab Genetics & Genomics - Insights

This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Laboratory Genetics and Genomics.

A novel testing approach for newly identified VEXAS syndrome - Insights

VEXAS syndrome is a severe autoinflammatory disease that results in a spectrum of rheumatologic and hematologic conditions. The underlying cause of newly identified VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome —...

About Us - Insights

Mayo Clinic Laboratories isn’t just a reference lab. We’re also the diagnostic lab for a hospital, just like your lab. So we know the many benefits of keeping tests as close to patients as possible.

Frequently asked questions - Insights

For patients at risk of plasma cell disorders, early identification is critical to ensure better outcomes. Mayo Clinic MASSFIX, our innovative approach uses matrix-assisted laser desorption/ionization time-of-flight mass spectrometry...

Frequently asked questions - Insights

For patients at risk of plasma cell disorders, early identification is critical to ensure better outcomes. Mayo Clinic MASSFIX, our innovative approach uses matrix-assisted laser desorption/ionization time-of-flight mass spectrometry...

Melanoma - Insights

Learn how our melanoma testing identifies variants in 17 genes associated with diagnosis, prognosis, and treatment guidance.

Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D. - Insights

Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' unique assay identifies pregnant women at risk of developing preeclampsia with severe features. Test results can guide clinical management, to safeguard maternal and neonatal...

August 2023 - Hematopathology - Insights

This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Hematopathology.

Updated testing algorithms for plasma cell proliferative disorders [Test in Focus] - Insights

Xinjie Xu, Ph.D., co-director of Mayo's Genetics and Genomics Laboratory, explains Mayo Clinic Laboratories' updated approach to testing for risk stratification of patients newly diagnosed with plasma cell proliferative disorders, such as...

Microlearning - Insights

Mayo Clinic Laboratories easily consumable content, ensuring knowledge retention in minimal time. These microlearning educational offerings will cover a variety of topics relevant to current and aspiring laboratory leaders.

Classical Hematology 2023 - Insights